After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
GT vs DC: Battle for top spot between Delhi and Gujarat, eyes on Siraj and Starc.
The 35th match of IPL 2025 will be played between Gujarat Titans and Delhi Capitals on Saturday (
Politics has now intensified over the violence in Birbhum, West Bengal. Many opposition leaders i
US-based crypto exchange Kraken has halted its staking service and had to pay a US$30 million fin
Russia said on Wednesday that it was monitoring developments on the Line of Actual
By-elections are going to be held for the lone Bochahan seat of the Bihar Legislative Assembly. T
Uttarakhand Election: Harak Singh Rawat joins Congress, expelled from BJP for anti-party activities
Former cabinet minister Harak Singh Rawat, who was expelled from the BJP for six years, has joine
Hamas Israel Conflict: Hamas attacks family, boy survives; death of parents
Deadly attacks continue between Hamas and Israel. Meanwhile, an Israeli-American teenager survive
Salman rubbished reports of getting a Rs 1000 crore fee for Bigg Boss 16. This season will start
India's 'Operation Sindoor' is going on, and once again the Pakistani team has lost badly on the
A strange case has emerged in Thailand. Here a man accidentally left his wife midway during a roa
